Health Care & Life Sciences » Pharmaceuticals | Taiko Pharmaceutical Co. Ltd.

Taiko Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
2,554
2,759
1,192
1,491
1,553
1,986
Depreciation, Depletion & Amortization
259
281
351
445
454
461
Other Funds
-
1,216
26
-
31
796
Funds from Operations
2,726
1,823
824
1,510
1,454
1,651
Changes in Working Capital
863
1,133
447
1,187
1,514
97
Net Operating Cash Flow
3,589
690
378
2,698
60
1,748
Capital Expenditures
304
2,881
3,756
122
138
Sale of Fixed Assets & Businesses
-
4
391
-
-
Purchase/Sale of Investments
323
130
728
50
3
Net Investing Cash Flow
621
2,755
2,636
72
114
Cash Dividends Paid - Total
191
325
320
196
283
Issuance/Reduction of Debt, Net
18
15
14
15
16
Net Financing Cash Flow
20
825
136
1,249
74
Net Change in Cash
3,089
2,784
2,442
3,806
255
Free Cash Flow
3,286
2,191
3,341
2,586
188
Other Sources
6
-
1
100
21
Change in Capital Stock
229
486
172
1,460
194
Exchange Rate Effect
100
106
48
68
8
Other Uses
-
7
-
-
-
Miscellaneous Funds
-
-
-
-
-

About Taiko Pharmaceutical Co.

View Profile
Address
ORIX Honmachi Building, 16F
Osaka Osaka 550
Japan
Employees -
Website http://www.seirogan.co.jp
Updated 07/08/2019
Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs, and sanitation control products. It operates through the following segments: Pharmaceuticals, Infection Control, and Others. The Pharmaceuticals segment handles the manufacture, procurement and sale of non-prescription (OTC) drugs in Japan and overseas.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.